•We present two cases of advanced uterine cancer that were treated with the combination of metronomic cyclophosphamide and bevacizumab.•Targeting angiogenesis can provide disease control in patients with advanced uterine cancer.•Randomized controlled trials comparing metronomic and conventional regimens in advanced uterine cancer are required.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4442644 | PMC |
| http://dx.doi.org/10.1016/j.gore.2014.12.004 | DOI Listing |
Publication Analysis
Top Keywords
advanced uterine
16
uterine cancer
12
metronomic cyclophosphamide
8
patients advanced
8
cyclophosphamide bevacizumab
4
bevacizumab disease
4
disease stabilization
4
stabilization patients
4
advanced
4
uterine
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!